CDR2 and ovarian cancer: Patients with ovarian cancer (OC) may develop anti‐Yo‐associated paraneoplastic cerebellar degeneration (PCD)—a cerebellar ataxia associated with tumor‐induced autoimmunity against CDR2 and CDR2L proteins.